Allows licensed pharmacists to prescribe FDA-approved medication assisted therapy for opioid use disorder under a non-patient-specific regimen.

New York Assembly Bill A03496 amends the public health law and the education law to allow licensed pharmacists to prescribe and order FDA-approved medication assisted therapy for opioid use disorder under a non-patient-specific regimen. This provision requires pharmacists to report administration to the patient's primary health care practitioner and refer patients to providers collaborating in the regimen. The bill also mandates that pharmacists register with the federal Drug Enforcement Administration and complete required training.

Allows licensed pharmacists to prescribe FDA-approved medication assisted therapy for opioid use disorder under a non-patient-specific regimen.

New York Assembly Bill A03496 amends the public health law and the education law to allow licensed pharmacists to prescribe and order FDA-approved medication assisted therapy for opioid use disorder under a non-patient-specific regimen. This provision requires pharmacists to report administration to the patient's primary health care practitioner and refer patients to providers collaborating in the regimen. The bill also mandates that pharmacists register with the federal Drug Enforcement Administration and complete required training.